AmirAli Talasaz, Co-Chief Executive Officer at Guardant Health, Inc. (GH), bought 184,000 shares at $97.82 ($17.7M) on 2021-11-19, disclosed to the SEC on 2021-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.82 | 37,721 | $3.7M | 20.9% |
| 2 | $97.82 | 37,721 | $3.7M | 20.9% |
| 3 | $98.78 | 12,279 | $1.2M | 6.9% |
| 4 | $98.78 | 12,279 | $1.2M | 6.9% |
| 5 | $92.42 | 6,033 | $558K | 3.2% |
| 6 | $92.42 | 6,033 |
| $558K |
| 3.2% |
| 7 | $93.05 | 23,467 | $2.2M | 12.3% |
| 8 | $93.05 | 23,467 | $2.2M | 12.3% |
| 9 | $94.00 | 5,000 | $470K | 2.7% |
| 10 | $95.50 | 5,000 | $478K | 2.7% |
| 11 | $96.83 | 14,900 | $1.4M | 8.2% |
| 12 | $98.00 | 100 | $10K | 0.1% |
| Total | $96.13 avg | 184,000 | $17.7M | 100% |
| Filing → |
| GH | SELL | 2026-05-22 | $23.1M | — | Filing → |
| GH | SELL | 2026-05-13 | $5.0M | — | Filing → |
| GH | SELL | 2025-12-10 | $8.5M | — | Filing → |